CAPTRUST Financial Advisors
OCDX

CAPTRUST Financial Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-313
Closed -$6K – 5306
2022
Q1 		$6K Buy
313
+52
+20% +$936 ﹤0.01% 4109
2021
Q4 		$6K Hold
261
– – ﹤0.01% 4028
2021
Q3 		$5K Hold
261
– – ﹤0.01% 3983
2021
Q2 		$6K Buy
+261
New +$5.31K ﹤0.01% 3820

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAPTRUST Financial Advisors's OCDX Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 313 shares — an estimated $6K sold.

CAPTRUST Financial Advisors first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $6K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 313 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $6K.
  • CAPTRUST Financial Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $6K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.